回复阿塞尔博等人。β受体阻滞剂在无左心室收缩功能障碍的心肌梗死患者中真的重要吗？对“萨比娜等人。心肌梗死且左心室射血功能保留患者的β受体阻滞剂：随机对照试验的系统评价和荟萃分析。2025年，，150”的评论。
Reply to Acerbo et al. Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on "Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2025, , 150".
作者信息
Sabina Michael, Trube Jennifer, Luna Graciela, Bizanti Anas
机构信息
Department of Internal Medicine Graduate Medical Education, Lakeland Regional Health Medical Center, Lakeland, FL 33805, USA.
出版信息
J Clin Med. 2025 Mar 26;14(7):2249. doi: 10.3390/jcm14072249.
Abstract
We appreciate the insightful commentary by Acerbo et al [...].
摘要
我们感谢Acerbo等人富有见地的评论[……]。
相似文献
1
Reply to Acerbo et al. Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on "Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2025, , 150".
J Clin Med. 2025 Mar 26;14(7):2249. doi: 10.3390/jcm14072249.
2
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. . 2025, , 150.
J Clin Med. 2025 Mar 26;14(7):2247. doi: 10.3390/jcm14072247.
3
Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Clin Med. 2024 Dec 30;14(1):150. doi: 10.3390/jcm14010150.
4
Reply to Dietvorst et al. Challenges in Providing an Overview of Results of Intermittent Fasting Interventions on Diabetes Parameters. Comment on "Silva et al. Effects of Intermittent Fasting on Regulation of Metabolic Homeostasis: A Systematic Review and Meta-Analysis in Health and Metabolic-Related Disorders. 2023, , 3699".
J Clin Med. 2024 Jul 12;13(14):4094. doi: 10.3390/jcm13144094.
5
Reply to Confalonieri et al. Comment on "Benekos et al. Intraocular Pressure Reduction Following Phacoemulsification in Patients with Exfoliation: A Systematic Review and Meta-Analysis. 2024, , 6774".
J Clin Med. 2025 Apr 9;14(8):2571. doi: 10.3390/jcm14082571.
6
Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):469-477. doi: 10.1177/2048872619830609. Epub 2019 Feb 14.
7
Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
Arq Bras Cardiol. 2015 Aug;105(2):145-50. doi: 10.5935/abc.20150055. Epub 2015 May 29.
8
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry.
Arch Cardiovasc Dis. 2023 Jan;116(1):25-32. doi: 10.1016/j.acvd.2022.10.007. Epub 2022 Dec 9.
9
Reply to Su et al. Comment on "Matsumoto et al. Remimazolam's Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial. 2023, , 5402".
J Clin Med. 2024 Feb 9;13(4):1002. doi: 10.3390/jcm13041002.
10
Reply to Mikhail et al. Comment on "Krysik et al. Clinical Outcomes and Early Postoperative Complications in Boston Type I Keratoprosthesis Implantation: A Retrospective Study. . 2024, , 6710".
J Clin Med. 2025 Feb 27;14(5):1614. doi: 10.3390/jcm14051614.
本文引用的文献
1
Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
J Clin Med. 2024 Dec 30;14(1):150. doi: 10.3390/jcm14010150.
2
Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial.
BMJ Open. 2024 Aug 31;14(8):e086971. doi: 10.1136/bmjopen-2024-086971.
3
Beta-Blocker Interruption or Continuation after Myocardial Infarction.
N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30.
4
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7.
5
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060.
6
The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis.
Clin Res Cardiol. 2021 Feb;110(2):183-193. doi: 10.1007/s00392-020-01697-8. Epub 2020 Jul 2.
7
Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
Trials. 2020 May 23;21(1):415. doi: 10.1186/s13063-020-4214-6.
8
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study.
Am Heart J. 2019 Feb;208:37-46. doi: 10.1016/j.ahj.2018.10.005. Epub 2018 Oct 25.
9
Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
PLoS One. 2018 Aug 28;13(8):e0199347. doi: 10.1371/journal.pone.0199347. eCollection 2018.
10
Sertraline treatment of major depression in patients with acute MI or unstable angina.
JAMA. 2002 Aug 14;288(6):701-9. doi: 10.1001/jama.288.6.701.
Zotero 插件